U.S.
Braze Up 52%, Yet Still 4% Below Salesforce's Price: Why?
On Oct. 20, Braze (BRZE) rose 51.7% on a filed Salesforce deal, while Lionsgate Studios (LION) and SELLAS Life Sciences (SLS) rose about 14% without filings.
Every time SELLAS Life Sciences (SLS) moved sharply, checked against filings and numbers. 1 article(s), newest first.
On Oct. 20, Braze (BRZE) rose 51.7% on a filed Salesforce deal, while Lionsgate Studios (LION) and SELLAS Life Sciences (SLS) rose about 14% without filings.